These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24411885)

  • 1. Re: comparison of the response to treatment between Asian and Caucasian men with benign prostatic hyperplasia: long-term results from the combination of dutasteride and tamsulosin study.
    Kaplan SA
    J Urol; 2014 Feb; 191(2):423-4. PubMed ID: 24411885
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the response to treatment between Asian and Caucasian men with benign prostatic hyperplasia: long-term results from the combination of dutasteride and tamsulosin study.
    Chung BH; Lee SH; Roehrborn CG; Siami PF; Major-Walker K; Wilson TH; Montorsi F;
    Int J Urol; 2012 Nov; 19(11):1031-5. PubMed ID: 22774774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combined dutasteride and tamsulosin].
    Sciarra A
    Urologia; 2011; 78(4):317-9. PubMed ID: 22101551
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comment to: «Cost-Effectiveness of the combination therapy of dutasteride and tamsulosin in the treatment of benign prostatic hyperlasia in Spain»].
    Miñana B
    Actas Urol Esp; 2011 Feb; 35(2):72. PubMed ID: 21324551
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness of single-dose tamsulosin and dutasteride combination therapy compared with tamsulosin monotherapy in patients with benign prostatic hyperplasia in the UK.
    Walker A; Doyle S; Posnett J; Hunjan M
    BJU Int; 2013 Sep; 112(5):638-46. PubMed ID: 23356792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dutasteride/tamsulosin fixed-dose combination for the treatment of benign prostatic enlargement.
    Ismail M; Hashim H
    Drugs Today (Barc); 2012 Jan; 48(1):17-24. PubMed ID: 22384457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dutasteride, tamsulosin and the combination on patient-reported quality of life and treatment satisfaction in men with moderate-to-severe benign prostatic hyperplasia: 4-year data from the CombAT study.
    Montorsi F; Henkel T; Geboers A; Mirone V; Arrosagaray P; Morrill B; Black L
    Int J Clin Pract; 2010 Jul; 64(8):1042-51. PubMed ID: 20487046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dutasteride on prostate biopsy rates and the diagnosis of prostate cancer in men with lower urinary tract symptoms and enlarged prostates in the Combination of Avodart and Tamsulosin trial.
    Roehrborn CG; Andriole GL; Wilson TH; Castro R; Rittmaster RS
    Eur Urol; 2011 Feb; 59(2):244-9. PubMed ID: 21093145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of dutasteride or tamsulosin alone and in combination on storage and voiding symptoms in men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH): 4-year data from the combination of avodart and tamsulosin (CombAT) study.
    Woo H
    BJU Int; 2011 May; 107(9):1431. PubMed ID: 21518231
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of combination therapy with dutasteride plus tamsulosin on clinical outcomes in men with symptomatic BPH: 4-year post hoc analysis of European men in the CombAT study.
    Haillot O; Fraga A; Maciukiewicz P; Pushkar D; Tammela T; Höfner K; Chantada V; Gagnier P; Morrill B
    Prostate Cancer Prostatic Dis; 2011 Dec; 14(4):302-6. PubMed ID: 21502969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can one manage well without measuring?
    Neulander EZ
    Int J Clin Pract; 2011 Mar; 65(3):373. PubMed ID: 21314877
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Effect of dutasteride on prostate biopsy rates and the diagnosis of prostate cancer in men with lower urinary tract symptoms and enlarged prostates in the combination of avodart and tamsulosin trial.
    Walsh PC
    J Urol; 2011 Apr; 185(4):1276-7. PubMed ID: 22098957
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of dutasteride or tamsulosin alone and in combination on storage and voiding symptoms in men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH): 4-year data from the Combination of Avodart and Tamsulosin (CombAT) study.
    Montorsi F; Roehrborn C; Garcia-Penit J; Borre M; Roeleveld TA; Alimi JC; Gagnier P; Wilson TH
    BJU Int; 2011 May; 107(9):1426-31. PubMed ID: 21348912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: The Effects of Combination Therapy With Dutasteride and Tamsulosin on Clinical Outcomes in Men With Symptomatic Benign Prostatic Hyperplasia: 4-Year Results From the CombAT Study.
    Kaplan SA
    J Urol; 2011 Apr; 185(4):1384-5. PubMed ID: 22115487
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trial.
    Roehrborn CG; Barkin J; Siami P; Tubaro A; Wilson TH; Morrill BB; Gagnier RP
    BJU Int; 2011 Mar; 107(6):946-54. PubMed ID: 21332630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cost-effectiveness of the combination therapy of dutasteride and tamsulosin in the treatment of benign prostatic hyperlasia in Spain].
    Antoñanzas F; Brenes F; Molero JM; Fernández-Pro A; Huerta A; Palencia R; Cozar JM
    Actas Urol Esp; 2011 Feb; 35(2):65-71. PubMed ID: 21269736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dutasteride/tamsulosin: in benign prostatic hyperplasia.
    Keating GM
    Drugs Aging; 2012 May; 29(5):405-19. PubMed ID: 22550968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study.
    Roehrborn CG; Siami P; Barkin J; Damião R; Major-Walker K; Nandy I; Morrill BB; Gagnier RP; Montorsi F;
    Eur Urol; 2010 Jan; 57(1):123-31. PubMed ID: 19825505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial comment to Early effect of dutasteride added to alpha-1 blocker therapy for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Maeda T
    Int J Urol; 2014 Aug; 21(8):819-20. PubMed ID: 24942824
    [No Abstract]   [Full Text] [Related]  

  • 20. [Medical treatment of patients with benign prostatic hyperplasia with 5-reductase inhibitors].
    Spivak LG; Platonova DV; Yagudaev DD
    Urologiia; 2019 Sep; (4):175-179. PubMed ID: 31535827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.